Enrolling By Invitation NA INTERVENTIONAL 1-arm NCT04195503

Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma

Liver Transplantation in Locally- Advanced, Unresectable, Non-Metastatic Intrahepatic Cholangiocarcinoma Treated With Neoadjuvant Systemic Therapy: A Single-centre, Pilot Study

Sponsor: University Health Network, Toronto

Conditions Cholangiocarcinoma, Intrahepatic

Interventions Liver Transplantation

Updated 8 times since 2020 Last updated: Oct 9, 2024 Started: Dec 10, 2019 Primary completion: Dec 31, 2029 Completion: Dec 31, 2034

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cholangiocarcinoma, Intrahepatic and is currently ongoing. University Health Network, Toronto leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Nov 2024 — Present [monthly]

Enrolling By Invitation NA
Sep 2024 — Nov 2024 [monthly]

Enrolling By Invitation NA
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation NA
Aug 2023 — Jul 2024 [monthly]

Enrolling By Invitation NA
May 2022 — Aug 2023 [monthly]

Enrolling By Invitation NA

▶ Show 3 earlier versions

Jan 2021 — May 2022 [monthly]

Enrolling By Invitation NA
Sep 2020 — Jan 2021 [monthly]

Enrolling By Invitation NA

Status: Not Yet Recruiting → Enrolling By Invitation
Jan 2020 — Sep 2020 [monthly]

Not Yet Recruiting NA

First recorded

Dec 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Health Network, Toronto

Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada